AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

April 30, 2016

Conditions
Advanced Breast Cancer
Interventions
DRUG

AZD2171

Oral tablet

DRUG

Fulvestrant

intramuscular injection

Trial Locations (16)

Unknown

Research Site, Burbank

Research Site, Los Angeles

Research Site, Palm Springs

Research Site, Boca Raton

Research Site, Honolulu

Research Site, New York

Research Site, Fitzroy

Research Site, Parkville

Research Site, Perth

Research Site, Waratah

Research Site, Belo Horizonte

Research Site, Curitiba

Research Site, Fortaleza

Research Site, Porto Alegre

Research Site, Santro Andre

Research Site, São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY